Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9626085

CCCCCCCCCCCCCCCCn1cnc(C)c1.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 known ✓ P11511 1/20 0.41
HSP90AA1 known ✓ P07900 1/20 0.41
TBXAS1 P24557 1/20 0.46
QPCT Q16769 10/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
HTT P42858 4/20 0.41
GALR3 O60755 2/20 0.41
POLB P06746 2/20 0.41
ATM Q13315 2/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9625488 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL2945045 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL19286072 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL9625860 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL9625581 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL16321117 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL1766186 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
SCHEMBL9773448 0.98 TBXAS1 (0.47) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
Bromide SCHEMBL10325056 0.96 TBXAS1 (0.46) TBXAS1QPCTCYP1A2CYP3A4CYP2D6
Iodide SCHEMBL10324529 0.96 TBXAS1 (0.46) TBXAS1QPCTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2615632-B1 MICROSTRUCTURE MANUFACTURING METHOD USING TREATMENT LIQUID FOR INHIBITING PATTERN COLLAPSE IN MICROSTRUCTURES MITSUBISHI GAS CHEMICAL CO (JP) 2019-05-08 EP disclosed
US-9334161-B2 Processing liquid for suppressing pattern collapse of fine metal structure and method for producing fine metal structure using same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-05-10 US disclosed
CN-103098180-B Processing liquid for suppressing pattern collapse of microstructure and method for producing microstructure using same MITSUBISHI GAS CHEMICAL CO.,INC. (JP) 2016-03-30 CN disclosed
US-8980812-B2 Treatment liquid for inhibiting pattern collapse in microstructures, and microstructure manufacturing method using said treatment liquid MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-03-17 US disclosed
CN-102575360-B Processing liquid for suppressing pattern collapse of fine metal structure and method for producing fine metal structure using same MITSUBISHI GAS CHEMICAL CO 2014-01-08 CN disclosed
EP-2615632-A1 TREATMENT LIQUID FOR INHIBITING PATTERN COLLAPSE IN MICROSTRUCTURES, AND MICROSTRUCTURE MANUFACTURING METHOD USING SAID TREATMENT LIQUID Mitsubishi Gas Chemical Company, Inc. (JP) 2013-07-17 EP disclosed
US-20130165365-A1 TREATMENT LIQUID FOR INHIBITING PATTERN COLLAPSE IN MICROSTRUCTURES, AND MICROSTRUCTURE MANUFACTURING METHOD USING SAID TREATMENT LIQUID MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-06-27 US disclosed
US-20120181249-A1 PROCESSING LIQUID FOR SUPPRESSING PATTERN COLLAPSE OF FINE METAL STRUCTURE AND METHOD FOR PRODUCING FINE METAL STRUCTURE USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-07-19 US disclosed
CN-102575360-A Processing liquid for suppressing pattern collapse of fine metal structure and method for producing fine metal structure using same MITSUBISHI GAS CHEMICAL CO 2012-07-11 CN disclosed
US-5143917-A Cationic tensides for controlling infections MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1992-09-01 US disclosed
US-5112844-A Micelles MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1992-05-12 US disclosed
US-5110929-A Quaternization of pyrazine compounds MEDICE CHAM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1992-05-05 US disclosed
US-5057518-A Substituted n-alkylpyrimidinium salts for absorbing hydrophobic drugs MEDICE HEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1991-10-15 US disclosed
US-5051435-A Micelles of triazolium compounds as cationic surfactants MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1991-09-24 US disclosed
US-4999435-A Cationic Surfactants, Drugs, Immunoassay MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1991-03-12 US disclosed
US-4965357-A CATIONIC TENSIDES, ANTIMETABOLITES MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1990-10-23 US disclosed
US-4894454-A BACTERICIDES MEDICE CHEM.-PHARM. FABRIK, PUTTER GMBH & CO., KG (DE) 1990-01-16 US disclosed
US-4882435-A CATIONIC TENSIDES; THIADIAZOLIUM SALTS MEDICE CHEM.-PHARM. FABRIK (DE) 1989-11-21 US disclosed
US-4877883-A CATIONIC SURFACTANTS MEDICE CHEM.-PHARM. FABRIK PUTTER GMBH & CO. KG (DE) 1989-10-31 US disclosed
US-4870174-A CATIONIC SURFACTANTS, SMALL CRITICAL MICELLE CONCENTRATIONS MEDICE CHEM.-PHARM. FABRIK (DE) 1989-09-26 US disclosed